Nanogen, Spectral Diagnostics deal

NGEN will acquire SDI's rapid cardiac immunoassay test business for C$5.65 million (US$4.9 million) in cash and C$3.35 million (US$2.9 million) in NGEN stock. The deal includes SDI's cardiac STATus, D...